GCTK

Glucotrack Inc Cross-source read$2.93 1.68%
Health CareCUSIP 45824Q804· EOD Sep 8, 2026

Among active 13F managers last quarter, 3 opened and 1 added, while none reduced or exited; the largest holder to move was Citadel Advisors LLC (new position). No open-market insider trades in the last 180 days.

Tracked 13F holders
15
6 in Q2 2026 filings
13F value (tracked)
$65K
Smart-money readBullish
Net sellingNet buying
Funds · active managers, latest 13F
4 adding · 0 trimming
Insiders · Form 4 open-market, 180d
0 buying · 0 selling
US House · STOCK Act, 180d
0 buying · 0 selling

Funds lean in and no leg opposes.

Price & smart-money activity

$2.93 1.68%5Y -100.0%
$2.70$157,952$315,901$473,850$631,80020212022202320242025202622222
Hover for who · click for detailEnd-of-day closing prices52w $2.93 – $158.85

Who owns GCTK?

15 tracked 13F filers · ranked by shares held

15 tracked 13F filers disclose a position in GCTK as of the latest SEC 13F filings, a combined $65K in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

#FundSharesPosition valueLast moveAs ofHistory
1Citadel Advisors LLC80K
$25K
New
+80K sh
Q2 2026
2Ikarian Capital, LLC46K
$15K
Held
Q2 2026
3Geode Capital Management, LLC34K
$11K
−27%
Reduced · −13K sh
Q2 2026
4Granite Islands Private Wealth, LLC16K
$5K
New
+16K sh
Q2 2026
5Boothbay Fund Management, LLC14K
$4K
Held
Q2 2026
6Alerus Financial Na4K
$1K
Held
Q2 2026
7Tower Research Capital LLC (TRC)3K
$2K
+710%
Added · +3K sh
Q1 2026
8PlanVest Financial, Inc1K
$319
New
+1K sh
Q2 2026
9UBS Group AG702
$456
+490%
Added · +583 sh
Q1 2026
10Tradewinds Capital Management, LLC50
$16
New
+50 sh
Q2 2026
11NFSG Corp34
$11
Held
Q2 2026
12SBI Securities Co., Ltd.9
$3
Held
Q2 2026
13Osaic Holdings, Inc.2
$1
+100%
Added · +1 sh
Q1 2026
14Morgan Stanley1
$1
Held
Q1 2026
15Royal Bank Of Canada1
$0
New
+1 sh
Q1 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Is GCTK being bought or sold by institutions?

Last quarter, 3 funds opened a new position in GCTK and 1 added to an existing one, while none reduced or exited. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).

Opened
3
funds took a first position
Added
1
added to an existing position
Biggest moves · ranked by size of the change, positions above a floor

Funds that own GCTK also own

CompanyCo-held byTheir position there
Nvidia CorpNVDA8 funds$3.1B
Amazon.com IncAMZN8 funds$2.8B
Apple IncAAPL8 funds$2.5B
Microsoft CorpMSFT8 funds$1.6B
Alphabet Inc-CL AGOOGL8 funds$1.3B
Broadcom IncAVGO8 funds$1.2B
Warner Bros Discovery IncWBD8 funds$1.2B
Eli Lilly & CoLLY8 funds$1.2B
Alphabet Inc-CL CGOOG8 funds$1.0B
Advanced Micro DevicesAMD8 funds$1.0B
Micron Technology IncMU8 funds$969.4M
Applied Materials IncAMAT8 funds$837.0M

Ranked by how many of GCTK's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in GCTK.

Insider activity (Form 4)

Full insider page →
Net · 180d
$0
0 open-market transactions
DateInsiderRoleActionSharesValue
Apr 22, 2024Sycoff DrewDirector, 10% OwnerBuy (P)183K$230K

Do institutions, insiders and Congress agree?

Mixed signals

Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.

SEC EDGAR 13F + Form 4 + US House STOCK Act{ }get_ticker_confluence · API & MCP

Signals by source

Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive

SourceBuyingSellingNet
13F funds
Top 100 holders by value, passive included; the hero counts active managers only
31
Insiders
Form 4 open-market
00$0
US House
STOCK Act trades
00$0
Sector rotation
GCTK is in Health Care, which smart money is rotating OUT OF
$5.0B

Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.

Institutional ownership over time

6 tracked filers in Q2 2026 filingsstill filing
0611Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
tracked filers holding their reported valueQ2 2026 filings so far: $18K
Each bar counts tracked filers with a position in that quarter's filings, so the newest bar excludes filers still on an earlier quarter. Arkolith's tracked universe has grown over this window; part of any long-run rise is coverage, not new buyers.

Recent filings

15 most recent

Keep exploring

Connected entities for GCTK

Browse more

Build

Ask your agent what changed in GCTK

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/GCTK/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for GCTK.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for GCTK. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.